$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > 樊嘉

信迪利单抗|最新研究

樊嘉院士:全球首个PD-1抑制剂联合治疗用于晚期肝癌一线治疗的Ⅲ期

肝癌|寻医问诊

樊嘉院士:全球首个PD-1抑制剂联合治疗用于晚期肝癌一线治疗的Ⅲ期
樊嘉院士团队在肝癌研究领域又一新突破!首次揭示肝癌原发肿瘤和早
樊嘉院士团队临床研究新突破:老药新用克服肝癌免疫治疗耐药